Fig. 1: Association of anti-SARS-CoV-2-spike IgG titer with age, COVID-19 severity, and cancer status. | Blood Cancer Journal

Fig. 1: Association of anti-SARS-CoV-2-spike IgG titer with age, COVID-19 severity, and cancer status.

From: Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients

Fig. 1

Violin plots depicting anti-s IgG titers, measured within 6 months from the first positive SARS-CoV-2 PCR, in hematologic malignancy (HM) patients grouped according to age, COVID-19 severity, and cancer status. Bars represent median (thick line) and interquartile range (dotted line). Statistical analysis was performed by Kruskal–Wallis and Dunn’s tests.

Back to article page